Brief: Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results

Verrica Pharmaceuticals

08/08/2023 13:30

Aug 8 (Reuters) - Verrica Pharmaceuticals Inc  VRCA.O :
    * VERRICA PHARMACEUTICALS REPORTS SECOND QUARTER 2023
FINANCIAL
RESULTS
    * VERRICA PHARMACEUTICALS INC Q2 EARNINGS PER SHARE VIEW
$-0.21 --
REFINITIV IBES DATA
    * VERRICA PHARMACEUTICALS INC Q2 NON-GAAP LOSS PER SHARE
$0.21
    * VERRICA PHARMACEUTICALS INC Q2 GAAP LOSS PER SHARE $0.24
    * VERRICA PHARMACEUTICALS INC - YCANTH™ LAUNCH EXPECTED BY
SEPTEMBER 2023
    * VERRICA PHARMACEUTICALS INC - CASH RUNWAY EXTENDED INTO Q1
OF
2025
    * VERRICA PHARMACEUTICALS INC - AS OF JUNE 30, 2023, VERRICA
HAD
AGGREGATE CASH AND CASH EQUIVALENTS OF $55.1 MILLION

Source text for Eikon:  ID:nGNX36GlXR 
Further company coverage:  VRCA.O